Skip to main content
Stephanie Halene, MD, Hematology, New Haven, CT

StephanieHaleneMD

Hematology New Haven, CT

Professor, Hematology, Comprehensive Cancer Center, Yale University School of Medicine

Dr. Halene is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Halene's full profile

Already have an account?

  • Office

    Park St.
    New Haven, CT 06520
    Phone+1 203-200-4363

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2006
  • Eberhard Karls University Faculty of Medicine
    Eberhard Karls University Faculty of MedicineClass of 1993

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2006 - 2025
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Journal Articles

  • SRSF2 Mutations Drive Oncogenesis by Activating a Global Program of Aberrant Alternative Splicing in Hematopoietic Cells  
    Radovan Vasic, Stephanie Halene, Nature

Abstracts/Posters

  • Variable Response to BCL2 Inhibition in MDS Is Enhanced across MDS Subtypes with Synergistic Combination of BCL2+MCL1 Inhibition
    Stephanie Halene, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience
    Stephanie Halene, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • LAM-003, a Novel Oral Heat Shock Protein 90 Inhibitor for Treatment of Acute Myeloid Leukemia, Including Wild-Type and FMS-like Tyrosine Kinase 3 (FLT3)-Mutant Disease
    Stephanie Halene, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Proton Sensor GPR68 Is Essential to Maintain Myeloid Malignancies 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • New Yale Study Shows Potential Target for Treating Blood Cancers
    New Yale Study Shows Potential Target for Treating Blood CancersMarch 31st, 2022
  • Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid Organs
    Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid OrgansOctober 20th, 2021
  • Student Research Day Celebrates Students and Mentors
    Student Research Day Celebrates Students and MentorsJune 1st, 2021
  • Join now to see all

Grant Support

  • Role Of C/Ebpepsilon In Myeloid DifferentiationNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010